MARKET

KALA

KALA

Kala Pharmaceuticals Inc
NASDAQ
2.930
-0.160
-5.18%
After Hours: 2.960 +0.03 +1.02% 16:48 05/15 EDT
OPEN
3.020
PREV CLOSE
3.090
HIGH
3.200
LOW
2.900
VOLUME
51.51K
TURNOVER
--
52 WEEK HIGH
1,030.00
52 WEEK LOW
2.850
MARKET CAP
54.47M
P/E (TTM)
-0.0177
1D
5D
1M
3M
1Y
5Y
1D
Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate
Benzinga · 1d ago
Kala Bio Q1 FY26 net loss narrows to $1.62 million
PUBT · 1d ago
KALA BIO: Q1 Earnings Snapshot
Barchart · 1d ago
Kala Bio falls -21.7%
TipRanks · 4d ago
Weekly Report: what happened at KALA last week (0504-0508)?
Weekly Report · 5d ago
Upcoming Stock Splits This Week (May 11 to May 15) – Stay Invested
TipRanks · 6d ago
Kala Pharmaceuticals trading halted, news pending
TipRanks · 05/08 23:50
Kala Bio files $350M mixed securities shelf
TipRanks · 05/07 22:27
More
About KALA
KALA BIO, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research, development, and commercialization of therapies for rare and severe diseases of the eye. The Company’s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. The Company’s product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biocfactors, such as growth factors, protease inhibitors, matrix proteins and neurotrophic factors that can potentially correct the impaired corneal healing, which is an underlying etiology of multiple severe ocular diseases; KPI-014 specific for inherited retinal degenerative diseases. KPI-012 is in clinical development for the treatment of persistent corneal epithelial defect (PCED), a rare disease of impaired corneal healing. The Company is also engaged in the development of KPI-012 for the treatment of Limbal Stem Cell Deficiency and other rare corneal diseases.

Webull offers KALA BIO Inc stock information, including NASDAQ: KALA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KALA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KALA stock methods without spending real money on the virtual paper trading platform.